Navigation Links


Sapacitabine in Medical Technology

Cyclacel Pharmaceuticals to Report Sapacitabine Phase I Study Results at the American Society of Clinical Oncology Annual Meeting

BERKELEY HEIGHTS, N.J.--(BUSINESS WIRE)--May 24, 2007 - Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP) announced today that it will report results from a Phase I pharmacologic trial of sapacitabine (CYC682), a novel orally-available nucleoside analog, in patients with advanced leukemi...

Cyclacel Pharmaceuticals to Present Preclinical Data on Sapacitabine and Seliciclib at AACR

...ll present results of two preclinical studies with sapacitabine and seliciclib, the company's most advanced drug c...geles Convention Center between April 14-18, 2007. sapacitabine is an orally-available, novel nucleoside analog in...pment in patients with non-small cell lung cancer. sapacitabine and seliciclib are the lead drug candidates in Cyc...
Sapacitabine in other areas

Sapacitabine - Wikipedia, the free encyclopedia

Antiproliferative effects of sapacitabine (CYC682), a novel 2'-deoxycytidine ... Retrieved from "http://en.wikipedia.org /wiki/ Sapacitabine" ...

CYCC Cyclacel Begins Phase 2 Study of Oral Sapacitabine in Patients ...

TradingMarkets News for CYCC - Cyclacel Begins Phase 2 Study of Oral Sapacitabine in Patients With Previously Treated Non-Small Cell Lung Cancer

CYCC Cyclacel Reports Phase 2 Sapacitabine Data in Patients With Acute ...

TradingMarkets News for CYCC - Cyclacel Reports Phase 2 Sapacitabine Data in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes At 2009 ASCO Annual ...

News: Cyclacel Expands Phase 2 Sapacitabine Trial in Elderly AML to ...

Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) (NASDAQ:CYCCP) announced that it has advanced sapacitabine into Phase 2 development as a second-line treatment for ...

Methods of treatment using sapacitabine

Further aspects of the invention relate to kits directed to the same. ... Sapacitabine, also known as 1-(2-C-cyano-2-deoxy-β-D-arabino-pentofuranosyl)-N4 ...

Cyclacel Expands Phase 2 Sapacitabine Trial In Elderly AML To ...

Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) (NASDAQ:CYCCP) announced that it has advanced sapacitabine into Phase 2 development as a second-line treatment for ...
Other TagsFormaFormaFormaFormaFormaFormaFormaDithioAmphetamineAmphetamineBorrelia
(Date:11/29/2009)... Traditional healthcare,s uncertain future and ...lternative care. Affordable Acupuncture Scottsdale...EB) November 29, 2009 -- Affordable Acupuncture, L...) and has been met with enthusiasm and gratitude. ... attributed to two things, need and cost. "A...
(Date:11/28/2009)...help lift spirits, recognize signs of depression ,... For many seniors, the holiday season can trigger ...ruggle with health issues or worry about money pro...y. , To help overcome the seasonal blues, the A...wing advice: , Get out and socialize or invite f...
(Date:11/27/2009)...CO, Nov. 27 The Gymboree... Lambert, CFO/COO, will present at the NASDAQ OMX ...ay Fair Hotel in London, England, on Wednesday, De... to a live broadcast of The Gymboree Corporation,s...www.gymboree.com, click on "Our Company" at the bo...
(Date:11/27/2009)...us low-emission vehicles may reduce future disease.... 27 (HealthDay News) -- Encouraging city dwellers...ffer much greater public health benefits than incr...ers have found. , The study compared the projec...nd transport scenarios for London, England, and De...
(Date:11/27/2009)... Specialist manufacturers who use medical load ...llions of dollars by bringing in technology partne...numbers of pro-active medical manufacturers are ca...stage of their projects, ensuring that progress wi... or potentially outdated technology. , ...
Breaking Medicine News(10 mins):Health News:Affordable Acupuncture Greeted with Open Arms by Scottsdale and Phoenix Communities 2Health News:Seniors May Need Help Overcoming Holiday Blues 2Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4
(Date:11/26/2009)...AMBRIDGE, Mass. (November 26, 2009) Whitehead res...en for human cells to pinpoint specific genes and ...er in Science . , In most human cell cultures g... the father and one from the mother. Gene inactiva...when one copy is inactivated, the second copy usua...
(Date:11/25/2009)...hrelin, a hormone produced in the stomach, may be ...ent of Parkinson,s disease, Yale School of Medicin...ent issue of the Journal of Neuroscience . , Pa...opamine neurons in an area of the midbrain known a...opamine production. Reduced production of dopamin...
(Date:11/25/2009)...ADISON, WI, NOVEMBER 25, 2009 Soil is the linchpi... and hydrosphere meet. Despite that, many students...but nothing more. Soil science educators are chall...blic recognize the critical importance of soil in ...oil science and earth science teachers at Universi...
Breaking Biology News(10 mins):Knockouts in human cells point to pathogenic targets 2Hormone ghrelin can boost resistance to Parkinson's disease 2It's not just dirt! 2Novo Nordisk Wins Design Award for NovoTwist 28TM 29 Needle 5671 1Novo Nordisk Wins Design Award for NovoTwist 28TM 29 Needle 5671 2Novo Nordisk Wins Design Award for NovoTwist 28TM 29 Needle 5671 3UC San Diego researchers reverse pulmonary arterial hypertension in mouse models 60038 1UC San Diego researchers reverse pulmonary arterial hypertension in mouse models 60038 2Testicular tumors may explain why some diseases are more common in children of older fathers 10512 1Testicular tumors may explain why some diseases are more common in children of older fathers 10512 2
Other Contentsviolenceviolenceviolenceviolenceverrucaconjunctivitisconjunctivitisarthritisarthritisarthritisarthritisarthritisarthritisarthritiscroupgastroenteritisgastroenteritisgastroenteritishemorrhagichemorrhagichemorrhagichemorrhagic